Additionally, intranasal insulin improves memory performance in those with advanced AD, mild cognitive impairment, and healthy people, which also retains the volume of the brain regions influenced by AD [29]. Figure 1 demonstrates how insulin resistance and comorbidities like obesity, can be a link between T2DM and AD. This evidence concerns the gene INS and Alzheimer disease.